161 related articles for article (PubMed ID: 37407963)
1. High accuracy epidermal growth factor receptor mutation prediction via histopathological deep learning.
Zhao D; Zhao Y; He S; Liu Z; Li K; Zhang L; Zhang X; Wang S; Che N; Jin M
BMC Pulm Med; 2023 Jul; 23(1):244. PubMed ID: 37407963
[TBL] [Abstract][Full Text] [Related]
2. [Prediction of gene mutation in lung cancer based on deep learning and histomorphology analysis].
Wang Q; Shen Q; Zhang Z; Cai C; Lu H; Zhou X; Xu J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Feb; 37(1):10-18. PubMed ID: 32096372
[TBL] [Abstract][Full Text] [Related]
3. Detection of an EGFR mutation in cytological specimens of lung adenocarcinoma.
Mohar B; Smojver Ježek S; Rajković Molek K; Štemberger C; Kurpis M; Kupanovac Ž; Samaržija M; Jonjić N; Grahovac B
Cytopathology; 2016 Dec; 27(6):444-451. PubMed ID: 26990359
[TBL] [Abstract][Full Text] [Related]
4. Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases.
Haim O; Abramov S; Shofty B; Fanizzi C; DiMeco F; Avisdris N; Ram Z; Artzi M; Grossman R
J Neurooncol; 2022 Mar; 157(1):63-69. PubMed ID: 35119589
[TBL] [Abstract][Full Text] [Related]
5. Deep learning-radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients.
Kim S; Lim JH; Kim CH; Roh J; You S; Choi JS; Lim JH; Kim L; Chang JW; Park D; Lee MW; Kim S; Heo J
Sci Rep; 2024 Jan; 14(1):922. PubMed ID: 38195717
[TBL] [Abstract][Full Text] [Related]
6. Prediction of epidermal growth factor receptor mutation subtypes in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning.
Zhang W; Wang W; Xu Y; Wu K; Shi J; Li M; Feng Z; Liu Y; Zheng Y; Wu H
Lab Invest; 2024 Jun; ():102094. PubMed ID: 38871058
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Whiting P; van Asselt T; Ramaekers B; Armstrong N; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2014 May; 18(32):1-166. PubMed ID: 24827857
[TBL] [Abstract][Full Text] [Related]
8. Predicting EGFR mutation, ALK rearrangement, and uncommon EGFR mutation in NSCLC patients by driverless artificial intelligence: a cohort study.
Tan X; Li Y; Wang S; Xia H; Meng R; Xu J; Duan Y; Li Y; Yang G; Ma Y; Jin Y
Respir Res; 2022 May; 23(1):132. PubMed ID: 35624472
[TBL] [Abstract][Full Text] [Related]
9. Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning.
Wang S; Shi J; Ye Z; Dong D; Yu D; Zhou M; Liu Y; Gevaert O; Wang K; Zhu Y; Zhou H; Liu Z; Tian J
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30635290
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.
Rybarczyk-Kasiuchnicz A; Ramlau R; Stencel K
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435596
[TBL] [Abstract][Full Text] [Related]
11. A radiomics-based deep learning approach to predict progression free-survival after tyrosine kinase inhibitor therapy in non-small cell lung cancer.
Lu CF; Liao CY; Chao HS; Chiu HY; Wang TW; Lee Y; Chen JR; Shiao TH; Chen YM; Wu YT
Cancer Imaging; 2023 Jan; 23(1):9. PubMed ID: 36670497
[TBL] [Abstract][Full Text] [Related]
12. Using Vision Transformer for high robustness and generalization in predicting EGFR mutation status in lung adenocarcinoma.
Weng L; Xu Y; Chen Y; Chen C; Qian Q; Pan J; Su H
Clin Transl Oncol; 2024 Jun; 26(6):1438-1445. PubMed ID: 38194018
[TBL] [Abstract][Full Text] [Related]
13. Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study.
Wang S; Yu H; Gan Y; Wu Z; Li E; Li X; Cao J; Zhu Y; Wang L; Deng H; Xie M; Wang Y; Ma X; Liu D; Chen B; Tian P; Qiu Z; Xian J; Ren J; Wang K; Wei W; Xie F; Li Z; Wang Q; Xue X; Liu Z; Shi J; Li W; Tian J
Lancet Digit Health; 2022 May; 4(5):e309-e319. PubMed ID: 35341713
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.
Liu X; Lu Y; Zhu G; Lei Y; Zheng L; Qin H; Tang C; Ellison G; McCormack R; Ji Q
J Clin Pathol; 2013 Dec; 66(12):1065-9. PubMed ID: 23888061
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China.
Zhou Y; Yang Y; Yang C; Chen Y; Yang C; Du Y; Zhao G; Guo Y; Ye L; Huang Y
Oncotarget; 2017 Feb; 8(9):15023-15033. PubMed ID: 28107191
[TBL] [Abstract][Full Text] [Related]
16. D3EGFR: a webserver for deep learning-guided drug sensitivity prediction and drug response information retrieval for EGFR mutation-driven lung cancer.
Shi Y; Li C; Zhang X; Peng C; Sun P; Zhang Q; Wu L; Ding Y; Xie D; Xu Z; Zhu W
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38555474
[TBL] [Abstract][Full Text] [Related]
17. Serum detection of epidermal growth factor receptor gene mutations using mutant-enriched sequencing in Chinese patients with advanced non-small cell lung cancer.
Jiang B; Liu F; Yang L; Zhang W; Yuan H; Wang J; Huang G
J Int Med Res; 2011; 39(4):1392-401. PubMed ID: 21986139
[TBL] [Abstract][Full Text] [Related]
18. Rare mutations of epidermal growth factor receptor in epidermal growth factor receptor-tyrosine kinase inhibitor-naive non-small cell lung carcinoma and the response to erlotinib therapy.
Sari M; Aydiner A
J Cancer Res Ther; 2020; 16(1):132-138. PubMed ID: 32362623
[TBL] [Abstract][Full Text] [Related]
19. Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutations.
Kato Y; Peled N; Wynes MW; Yoshida K; Pardo M; Mascaux C; Ohira T; Tsuboi M; Matsubayashi J; Nagao T; Ikeda N; Hirsch FR
J Thorac Oncol; 2010 Oct; 5(10):1551-8. PubMed ID: 20697298
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling and utility of cell-free DNA in nonsmall carcinoma of the lung: Study in a tertiary care hospital.
Ghosh M; Mukhopadhyay M; Das C; Chatterjee S; Naskar BG
J Cancer Res Ther; 2021; 17(6):1389-1396. PubMed ID: 34916369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
